Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H18N4O.ClH |
Molecular Weight | 306.791 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.O=C(N[C@@H]1CN2CCC1CC2)C3=NNC4=C3C=CC=C4
InChI
InChIKey=CMRLNEYJEPELSM-BTQNPOSSSA-N
InChI=1S/C15H18N4O.ClH/c20-15(14-11-3-1-2-4-12(11)17-18-14)16-13-9-19-7-5-10(13)6-8-19;/h1-4,10,13H,5-9H2,(H,16,20)(H,17,18);1H/t13-;/m1./s1
Molecular Formula | C15H18N4O |
Molecular Weight | 270.3296 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | ClH |
Molecular Weight | 36.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Facinicline (MEM-63908 or R-4996) is a selective nicotinic alpha-7 receptor (α7nAChR) partial agonist. It also has properties of a serotonin 3 receptor antagonist. It has hydrochloride form: RG3487 (formerly MEM3454). Facinicline enhances DA efflux by nAChR stimulation, whereas ACh efflux is primarily mediated via 5-HT3 receptor antagonism. It improves cognition and sensorimotor gating in rodents. It has been tested in Alzheimer's disease and cognitive symptoms of schizophrenia.
CNS Activity
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
RG3487, a novel nicotinic α7 receptor partial agonist, improves cognition and sensorimotor gating in rodents. | 2011 Jan |
|
A randomized, placebo-controlled study investigating the nicotinic α7 agonist, RG3487, for cognitive deficits in schizophrenia. | 2014 Jun |
|
The alpha-7 nicotinic receptor partial agonist/5-HT3 antagonist RG3487 enhances cortical and hippocampal dopamine and acetylcholine release. | 2014 May |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 11:09:40 GMT 2023
by
admin
on
Sat Dec 16 11:09:40 GMT 2023
|
Record UNII |
O6J463N18M
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
677305-02-1
Created by
admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
|
PRIMARY | |||
|
909910-22-1
Created by
admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
|
NO STRUCTURE GIVEN | |||
|
CHEMBL3544952
Created by
admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
|
PRIMARY | |||
|
DBSALT002602
Created by
admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
|
PRIMARY | |||
|
O6J463N18M
Created by
admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
|
PRIMARY | |||
|
10380472
Created by
admin on Sat Dec 16 11:09:40 GMT 2023 , Edited by admin on Sat Dec 16 11:09:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
TARGET -> AGONIST |
(.ALPHA.7 NACHR) IN VITRO DATA KI = 6 NM (R)
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |